294 related articles for article (PubMed ID: 25145931)
1. Sphingosine 1-phosphate receptor-1 enhances mitochondrial function and reduces cisplatin-induced tubule injury.
Bajwa A; Rosin DL; Chroscicki P; Lee S; Dondeti K; Ye H; Kinsey GR; Stevens BK; Jobin K; Kenwood BM; Hoehn KL; Lynch KR; Okusa MD
J Am Soc Nephrol; 2015 Apr; 26(4):908-25. PubMed ID: 25145931
[TBL] [Abstract][Full Text] [Related]
2. Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury.
Bajwa A; Jo SK; Ye H; Huang L; Dondeti KR; Rosin DL; Haase VH; Macdonald TL; Lynch KR; Okusa MD
J Am Soc Nephrol; 2010 Jun; 21(6):955-65. PubMed ID: 20338995
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine-1-phosphate receptor 1 agonism attenuates lung ischemia-reperfusion injury.
Stone ML; Sharma AK; Zhao Y; Charles EJ; Huerter ME; Johnston WF; Kron IL; Lynch KR; Laubach VE
Am J Physiol Lung Cell Mol Physiol; 2015 Jun; 308(12):L1245-52. PubMed ID: 25910934
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor.
Oo ML; Thangada S; Wu MT; Liu CH; Macdonald TL; Lynch KR; Lin CY; Hla T
J Biol Chem; 2007 Mar; 282(12):9082-9. PubMed ID: 17237497
[TBL] [Abstract][Full Text] [Related]
5. FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.
Brinkmann V
Br J Pharmacol; 2009 Nov; 158(5):1173-82. PubMed ID: 19814729
[TBL] [Abstract][Full Text] [Related]
6. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.
Choi JW; Gardell SE; Herr DR; Rivera R; Lee CW; Noguchi K; Teo ST; Yung YC; Lu M; Kennedy G; Chun J
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):751-6. PubMed ID: 21177428
[TBL] [Abstract][Full Text] [Related]
7. Systematic review and meta-analysis of the efficacy of sphingosine-1-phosphate (S1P) receptor agonist FTY720 (fingolimod) in animal models of stroke.
Liu J; Zhang C; Tao W; Liu M
Int J Neurosci; 2013 Mar; 123(3):163-9. PubMed ID: 23167788
[TBL] [Abstract][Full Text] [Related]
8. Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model.
Kim HJ; Miron VE; Dukala D; Proia RL; Ludwin SK; Traka M; Antel JP; Soliven B
FASEB J; 2011 May; 25(5):1509-18. PubMed ID: 21248243
[TBL] [Abstract][Full Text] [Related]
9. Non-phosphorylated FTY720 induces apoptosis of human microglia by activating SREBP2.
Yoshino T; Tabunoki H; Sugiyama S; Ishii K; Kim SU; Satoh J
Cell Mol Neurobiol; 2011 Oct; 31(7):1009-20. PubMed ID: 21519925
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
Hofmann U; Burkard N; Vogt C; Thoma A; Frantz S; Ertl G; Ritter O; Bonz A
Cardiovasc Res; 2009 Jul; 83(2):285-93. PubMed ID: 19416991
[TBL] [Abstract][Full Text] [Related]
11. S1P1 receptor inhibits kidney epithelial mesenchymal transition triggered by ischemia/reperfusion injury via the PI3K/Akt pathway.
Wang W; Wang A; Luo G; Ma F; Wei X; Bi Y
Acta Biochim Biophys Sin (Shanghai); 2018 Jul; 50(7):651-657. PubMed ID: 29901713
[TBL] [Abstract][Full Text] [Related]
12. Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes.
Awad AS; Rouse MD; Khutsishvili K; Huang L; Bolton WK; Lynch KR; Okusa MD
Kidney Int; 2011 May; 79(10):1090-8. PubMed ID: 21289599
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury.
Natarajan V; Dudek SM; Jacobson JR; Moreno-Vinasco L; Huang LS; Abassi T; Mathew B; Zhao Y; Wang L; Bittman R; Weichselbaum R; Berdyshev E; Garcia JG
Am J Respir Cell Mol Biol; 2013 Jul; 49(1):6-17. PubMed ID: 23449739
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary endothelial cell barrier enhancement by FTY720 does not require the S1P1 receptor.
Dudek SM; Camp SM; Chiang ET; Singleton PA; Usatyuk PV; Zhao Y; Natarajan V; Garcia JG
Cell Signal; 2007 Aug; 19(8):1754-64. PubMed ID: 17475445
[TBL] [Abstract][Full Text] [Related]
15. The sphingosine-1-phosphate receptor agonist FTY720 prevents the development of anti-glomerular basement membrane glomerulonephritis.
Sui M; Zhou J; Xie R; Liu X; Mu S; Jia X; Ma J; Wu H
Mol Biol Rep; 2012 Jan; 39(1):389-97. PubMed ID: 21833515
[TBL] [Abstract][Full Text] [Related]
16. Prolonging survival of corneal transplantation by selective sphingosine-1-phosphate receptor 1 agonist.
Gao M; Liu Y; Xiao Y; Han G; Jia L; Wang L; Lei T; Huang Y
PLoS One; 2014; 9(9):e105693. PubMed ID: 25216235
[TBL] [Abstract][Full Text] [Related]
17. FTY720 modulates human oligodendrocyte progenitor process extension and survival.
Miron VE; Jung CG; Kim HJ; Kennedy TE; Soliven B; Antel JP
Ann Neurol; 2008 Jan; 63(1):61-71. PubMed ID: 17918267
[TBL] [Abstract][Full Text] [Related]
18. Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats.
Hasegawa Y; Suzuki H; Sozen T; Rolland W; Zhang JH
Stroke; 2010 Feb; 41(2):368-74. PubMed ID: 19940275
[TBL] [Abstract][Full Text] [Related]
19. FTY720 Regulates Mitochondria Biogenesis in Dendritic Cells to Prevent Kidney Ischemic Reperfusion Injury.
Rousselle TV; Kuscu C; Kuscu C; Schlegel K; Huang L; Namwanje M; Eason JD; Makowski L; Maluf D; Mas V; Bajwa A
Front Immunol; 2020; 11():1278. PubMed ID: 32670281
[TBL] [Abstract][Full Text] [Related]
20. FTY720 (s)-phosphonate preserves sphingosine 1-phosphate receptor 1 expression and exhibits superior barrier protection to FTY720 in acute lung injury.
Wang L; Sammani S; Moreno-Vinasco L; Letsiou E; Wang T; Camp SM; Bittman R; Garcia JG; Dudek SM
Crit Care Med; 2014 Mar; 42(3):e189-99. PubMed ID: 24335440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
